Pharmacological Properties of ABT-239 [4-(2-{2-[(2 R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological Characterization and Broad Preclinical Efficacy in Cognition and Schizophrenia of a Potent and Selective Histamine H3 Receptor Antagonist
Gerard B. Fox(Abbott Fund), Timothy A. Esbenshade, Jia Bao Pan, Richard J. Radek, Kathleen M. Krueger, Betty Yao, Kaitlin E. Browman, Michael Buckley, Michael E. Ballard, Victoria A. Komater, Holly M. Miner, Min Zhang, Ramin Faghih, Lynne E. Rueter, Robert S. Bitner, Karla Drescher, Jill M. Wetter, Kennan C. Marsh, Martine Lemaire‐Chamley, Roger D. Porsolt, Youssef L. Bennani, James P. Sullivan, Marlon Cowart, Michael Decker, Arthur A. Hancock
Cited by 261
Abstract
Related Papers
No related papers found
Powered by citation graph analysis